Isis and Johnson & Johnson validation program

ISIP's GeneTrove division and the R.W. Johnson Pharmaceutical Research Institute (PRI) (Raritan, N.J.), a JNJ subsidiary, will use GeneTrove's antisense technology to assess and prioritize genes as dr...